 Gabriela Garcia
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulonephritis | 3 | 2021 | 46 | 1.350 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2023 | 566 | 0.950 |
Why?
| | Kidney Diseases | 4 | 2023 | 382 | 0.850 |
Why?
| | Uric Acid | 10 | 2021 | 161 | 0.840 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 9 | 0.740 |
Why?
| | Fructose | 8 | 2023 | 106 | 0.720 |
Why?
| | Fructokinases | 6 | 2023 | 31 | 0.630 |
Why?
| | Inflammation | 3 | 2022 | 2737 | 0.590 |
Why?
| | Fibrosis | 2 | 2021 | 520 | 0.550 |
Why?
| | Glomerular Basement Membrane | 2 | 2020 | 7 | 0.530 |
Why?
| | Macrophages | 3 | 2021 | 1484 | 0.510 |
Why?
| | Kidney | 7 | 2023 | 1385 | 0.480 |
Why?
| | Hyperuricemia | 3 | 2021 | 44 | 0.460 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2015 | 104 | 0.460 |
Why?
| | Protein Subunits | 1 | 2015 | 234 | 0.440 |
Why?
| | Dehydration | 4 | 2023 | 49 | 0.370 |
Why?
| | Metabolic Syndrome | 3 | 2023 | 339 | 0.350 |
Why?
| | Heat Stress Disorders | 2 | 2023 | 69 | 0.340 |
Why?
| | AMP Deaminase | 3 | 2015 | 10 | 0.340 |
Why?
| | Podocytes | 2 | 2020 | 52 | 0.310 |
Why?
| | Fatty Liver | 3 | 2018 | 230 | 0.290 |
Why?
| | Heat-Shock Response | 2 | 2018 | 72 | 0.290 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 8 | 0.210 |
Why?
| | Nephrology | 1 | 2023 | 60 | 0.190 |
Why?
| | Aminopterin | 1 | 2021 | 2 | 0.190 |
Why?
| | Hot Temperature | 3 | 2019 | 369 | 0.190 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 52 | 0.180 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2021 | 89 | 0.180 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 82 | 0.180 |
Why?
| | Japan | 5 | 2017 | 98 | 0.170 |
Why?
| | Receptors, Fc | 1 | 2020 | 52 | 0.170 |
Why?
| | Animals | 16 | 2023 | 35307 | 0.170 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 109 | 0.170 |
Why?
| | Methotrexate | 1 | 2021 | 248 | 0.170 |
Why?
| | Hypertension | 3 | 2017 | 1242 | 0.170 |
Why?
| | Folic Acid | 1 | 2021 | 184 | 0.170 |
Why?
| | Glomerular Filtration Rate | 3 | 2021 | 711 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2020 | 200 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2537 | 0.160 |
Why?
| | Rats | 4 | 2022 | 5482 | 0.150 |
Why?
| | Diabetes Mellitus | 2 | 2017 | 1000 | 0.150 |
Why?
| | Kidney Calculi | 1 | 2018 | 35 | 0.150 |
Why?
| | Mice, Inbred C57BL | 7 | 2019 | 5439 | 0.150 |
Why?
| | B7-1 Antigen | 1 | 2018 | 61 | 0.150 |
Why?
| | Proteinuria | 1 | 2018 | 91 | 0.140 |
Why?
| | Nanoparticles | 1 | 2022 | 375 | 0.140 |
Why?
| | Obesity, Metabolically Benign | 1 | 2017 | 4 | 0.140 |
Why?
| | Prehypertension | 1 | 2017 | 27 | 0.140 |
Why?
| | Fluid Therapy | 1 | 2018 | 133 | 0.140 |
Why?
| | Urinary Calculi | 1 | 2017 | 11 | 0.140 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2015 | 191 | 0.130 |
Why?
| | Asymptomatic Diseases | 1 | 2017 | 84 | 0.130 |
Why?
| | Vasopressins | 1 | 2016 | 64 | 0.130 |
Why?
| | Hypothalamus | 1 | 2016 | 149 | 0.130 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2014 | 183 | 0.130 |
Why?
| | Mice | 9 | 2023 | 16915 | 0.130 |
Why?
| | Sodium | 1 | 2017 | 205 | 0.120 |
Why?
| | Energy Metabolism | 2 | 2019 | 873 | 0.120 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2015 | 8 | 0.120 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2015 | 15 | 0.120 |
Why?
| | Albuminuria | 1 | 2016 | 183 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2017 | 177 | 0.120 |
Why?
| | Fibrin | 1 | 2015 | 68 | 0.120 |
Why?
| | Hepatocytes | 2 | 2012 | 216 | 0.110 |
Why?
| | Hibernation | 1 | 2015 | 74 | 0.110 |
Why?
| | Starvation | 1 | 2014 | 22 | 0.110 |
Why?
| | Gluconeogenesis | 1 | 2014 | 76 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 125 | 0.110 |
Why?
| | Mitochondria | 1 | 2019 | 877 | 0.100 |
Why?
| | Adenylate Kinase | 1 | 2012 | 26 | 0.100 |
Why?
| | Collagen | 1 | 2015 | 433 | 0.100 |
Why?
| | Mice, Knockout | 5 | 2020 | 2871 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 455 | 0.100 |
Why?
| | Obesity | 3 | 2023 | 2879 | 0.100 |
Why?
| | Kidney Transplantation | 1 | 2018 | 671 | 0.090 |
Why?
| | Mice, Obese | 2 | 2023 | 59 | 0.090 |
Why?
| | Liver | 3 | 2015 | 1839 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2015 | 590 | 0.090 |
Why?
| | Diabetic Nephropathies | 1 | 2014 | 284 | 0.090 |
Why?
| | Cytokines | 2 | 2015 | 2013 | 0.080 |
Why?
| | Risk Factors | 6 | 2018 | 9745 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4057 | 0.080 |
Why?
| | Hep G2 Cells | 3 | 2014 | 61 | 0.080 |
Why?
| | Climate Change | 2 | 2023 | 160 | 0.080 |
Why?
| | Male | 12 | 2018 | 63501 | 0.080 |
Why?
| | Kidney Tubules | 2 | 2019 | 114 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2019 | 152 | 0.070 |
Why?
| | Humans | 15 | 2023 | 129248 | 0.070 |
Why?
| | Cohort Studies | 4 | 2018 | 5408 | 0.070 |
Why?
| | Aging | 1 | 2016 | 1774 | 0.060 |
Why?
| | Body Mass Index | 3 | 2018 | 2272 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2003 | 0.060 |
Why?
| | Middle Aged | 7 | 2018 | 31087 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2018 | 14455 | 0.050 |
Why?
| | Dietary Sucrose | 1 | 2023 | 48 | 0.050 |
Why?
| | Logistic Models | 2 | 2017 | 1984 | 0.050 |
Why?
| | Isoenzymes | 2 | 2012 | 302 | 0.050 |
Why?
| | Sex Factors | 2 | 2017 | 1965 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 110 | 0.050 |
Why?
| | Adult | 6 | 2018 | 35495 | 0.040 |
Why?
| | Female | 6 | 2018 | 68543 | 0.040 |
Why?
| | Incidence | 2 | 2017 | 2636 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 1028 | 0.040 |
Why?
| | Blood Pressure | 2 | 2017 | 1736 | 0.040 |
Why?
| | Calcium Oxalate | 1 | 2018 | 5 | 0.040 |
Why?
| | Nephrosis | 1 | 2018 | 4 | 0.040 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.040 |
Why?
| | Aged | 4 | 2018 | 22032 | 0.040 |
Why?
| | Abatacept | 1 | 2018 | 46 | 0.040 |
Why?
| | Nephrosis, Lipoid | 1 | 2018 | 10 | 0.040 |
Why?
| | CD40 Ligand | 1 | 2018 | 38 | 0.040 |
Why?
| | Papio | 1 | 2018 | 91 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 74 | 0.040 |
Why?
| | Urinalysis | 1 | 2018 | 75 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 87 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 192 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2021 | 423 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 256 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 228 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 478 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1155 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2017 | 166 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 153 | 0.030 |
Why?
| | Time Factors | 2 | 2017 | 6543 | 0.030 |
Why?
| | Age Distribution | 1 | 2017 | 372 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 75 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 359 | 0.030 |
Why?
| | Swine | 1 | 2018 | 760 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2016 | 203 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2017 | 7055 | 0.030 |
Why?
| | Water | 1 | 2018 | 440 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 819 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 25 | 0.030 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2014 | 15 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2014 | 31 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 491 | 0.030 |
Why?
| | Urate Oxidase | 1 | 2014 | 11 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2014 | 60 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 833 | 0.030 |
Why?
| | History, Ancient | 1 | 2014 | 52 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 140 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 62 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2018 | 848 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 128 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2016 | 1288 | 0.030 |
Why?
| | Sciuridae | 1 | 2015 | 146 | 0.030 |
Why?
| | Hominidae | 1 | 2014 | 81 | 0.030 |
Why?
| | Europe | 1 | 2014 | 363 | 0.030 |
Why?
| | Chemokines | 1 | 2014 | 226 | 0.030 |
Why?
| | Phosphates | 1 | 2014 | 179 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 4076 | 0.030 |
Why?
| | Carbon-Carbon Double Bond Isomerases | 1 | 2012 | 2 | 0.030 |
Why?
| | Fats | 1 | 2012 | 14 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 24 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 286 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 155 | 0.030 |
Why?
| | Allopurinol | 1 | 2012 | 62 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1869 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 494 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2014 | 249 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1544 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 426 | 0.020 |
Why?
| | Phosphorylation | 1 | 2016 | 1710 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1946 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 497 | 0.020 |
Why?
| | Databases, Factual | 1 | 2017 | 1266 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 648 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 396 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2012 | 812 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 367 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3140 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 477 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2554 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2630 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 939 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 1001 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2716 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 839 | 0.020 |
Why?
| | Lung | 1 | 2022 | 3926 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2703 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 827 | 0.020 |
Why?
| | Metformin | 1 | 2012 | 315 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3772 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3233 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2396 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 1722 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2012 | 622 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5045 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2014 | 1165 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3966 | 0.020 |
Why?
| | Blood Glucose | 1 | 2014 | 2097 | 0.010 |
Why?
| | Insulin | 1 | 2014 | 2325 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 20303 | 0.010 |
Why?
|
|
Garcia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|